Related Experiment Video

Updated: Aug 25, 2026

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Inhibition of CDKs: a strategy for preventing kainic acid-induced apoptosis in neurons

E Verdaguer1, Elvira G Jordà, Alessandra Stranges

  • 1Unitat de Farmacologia i Farmacognòsia, Facultat de Farmàcia, Universitat de Barcelona, Barcelona, Spain. verdague@farmacia.far.ub.es

Annals of the New York Academy of Sciences
|March 23, 2004
PubMed

Insights

Cyclin-dependent kinase (CDK) inhibitors reduce neuronal apoptosis caused by kainic acid stimulation of AMPA/KA receptors. This suggests CDK activation contributes to neurodegeneration in Alzheimer's and Parkinson's diseases.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Cell Biology

Background:

  • Ionotropic glutamate receptor stimulation is linked to neurodegenerative diseases like Alzheimer's and Parkinson's.
  • Cell cycle proteins are expressed in vulnerable neurons in Alzheimer's disease.

Purpose of the Study:

  • To investigate cell cycle protein expression in cerebellar granule cells after AMPA/KA receptor stimulation.
  • To assess the neuroprotective potential of CDK inhibitors against excitotoxicity.

Main Methods:

  • Cerebellar granule cells were stimulated with kainic acid.
  • The effects of CDK inhibitors (flavopiridol, 3-ATA) on apoptosis were evaluated.
  • Apoptotic nuclei were quantified.

Main Results:

  • Kainic acid treatment induced significant apoptosis in cerebellar granule cells.
  • Flavopiridol and 3-ATA significantly reduced kainic acid-induced apoptotic nuclei.
  • CDK inhibitors demonstrated neuroprotective effects.

Conclusions:

  • CDK activation plays a role in the pro-apoptotic effects of kainic acid.
  • Targeting CDK pathways may offer therapeutic strategies for neurodegenerative diseases.

More Related Videos

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.